Is Karo Pharma AB publ stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Karo Pharma AB publ pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Friday 12th of May 2017 were paid $0.22414 per share. Over the last 1 times between 2017 and 2017, Karo Pharma AB publ has paid $0.22414 with an average of $0.22 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Karo Pharma AB publ 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $3.99, you would have made a profit of $1.260 per share or 31.58%
We do not have enough data to give you this answer.
Karo Pharma AB publ has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Karo Pharma AB publ to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.